<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">31677965</PMID><DateCompleted><Year>2021</Year><Month>07</Month><Day>05</Day></DateCompleted><DateRevised><Year>2021</Year><Month>07</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-9157</ISSN><JournalIssue CitedMedium="Internet"><Volume>107</Volume><PubDate><Year>2020</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Journal of autoimmunity</Title><ISOAbbreviation>J Autoimmun</ISOAbbreviation></Journal><ArticleTitle>Salivary dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus.</ArticleTitle><Pagination><StartPage>102354</StartPage><MedlinePgn>102354</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jaut.2019.102354</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0896-8411(19)30585-2</ELocationID><Abstract><AbstractText>Mothers giving birth to children with manifestations of neonatal lupus (NL) represent a unique population at risk for the development of clinically evident pathologic autoimmunity since many are asymptomatic and only become aware of anti-SSA/Ro positivity (anti-Ro+) based on heart block in their fetus. Accordingly, we hypothesized that the microbiome in saliva is associated with the development of autoreactivity and in some cases the progression in health status from benign to overt clinical disease including Sj&#xf6;gren's syndrome (SS) and systemic lupus erythematosus (SLE). The study comprised a clinical spectrum of anti-Ro+&#xa0;mothers, all of whom gave birth to a child with NL: 9 were asymptomatic or had an undifferentiated autoimmune disease (Asym/UAS) and 16 fulfilled criteria for SS and/or SLE. Microbial diversity was reduced across all levels from kingdom to species for the anti-Ro+&#xa0;mothers vs healthy controls; however, there were no significant differences between Asym/UAS and SS/SLE mothers. Relative abundance of Proteobacteria and more specifically class Betaproteobacteria decreased with clinical severity (healthy controls &lt;&#x202f;Asym/UAS&#x202f;&lt;&#x202f;SS/SLE). These ordered differences were maintained through the taxonomic hierarchy to three genera (Lautropia, Comamonas, and Neisseria) and species within these genera (L. mirabilis, N. flavescens and N. oralis). Biometric analysis comparing von Willebrand Factor domains present in human Ro60 with L. mirabilis proteins support the hypothesis of molecular mimicry. These data position the microbiome in the development of anti-Ro reactivity and subsequent clinical spectrum of disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2019 Elsevier Ltd. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Clancy</LastName><ForeName>R M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>NYU Langone Health, Department of Medicine, Division of Rheumatology, New York, NY, USA. Electronic address: robert.clancy@nyulangone.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marion</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ainsworth</LastName><ForeName>H C</ForeName><Initials>HC</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blaser</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Rutgers University, Center for Advanced Biotechnology and Medicine, Piscataway, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NYU Langone Health, Department of Medicine, Division of Rheumatology, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Howard</LastName><ForeName>T D</ForeName><Initials>TD</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Izmirly</LastName><ForeName>P M</ForeName><Initials>PM</Initials><AffiliationInfo><Affiliation>NYU Langone Health, Department of Medicine, Division of Rheumatology, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lacher</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Rutgers University, Center for Advanced Biotechnology and Medicine, Piscataway, NJ, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masson</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NYU Langone Health, Department of Medicine, Division of Rheumatology, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>NYU Langone Health, Department of Medicine, Division of Rheumatology, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buyon</LastName><ForeName>J P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>NYU Langone Health, Department of Medicine, Division of Rheumatology, New York, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langefeld</LastName><ForeName>C D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem, NC, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA016087</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AR070591</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AR071106</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Autoimmun</MedlineTA><NlmUniqueID>8812164</NlmUniqueID><ISSNLinking>0896-8411</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000974">Antibodies, Antinuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D001323">Autoantibodies</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006680">HLA Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C536397">Neonatal Systemic lupus erythematosus</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000974" MajorTopicYN="N">Antibodies, Antinuclear</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001323" MajorTopicYN="N">Autoantibodies</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015551" MajorTopicYN="N">Autoimmunity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044822" MajorTopicYN="N">Biodiversity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="Y">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006680" MajorTopicYN="N">HLA Antigens</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000151" MajorTopicYN="Y">congenital</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064307" MajorTopicYN="N">Microbiota</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011297" MajorTopicYN="Y">Prenatal Exposure Delayed Effects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012469" MajorTopicYN="N">Salivary Glands</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Autoantibodies</Keyword><Keyword MajorTopicYN="N">Autoimmunity</Keyword><Keyword MajorTopicYN="N">Human</Keyword><Keyword MajorTopicYN="N">Microbiome</Keyword></KeywordList><CoiStatement>Declaration of competing interest None.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>9</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>11</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>7</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>11</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31677965</ArticleId><ArticleId IdType="mid">NIHMS1543124</ArticleId><ArticleId IdType="pmc">PMC7192221</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2019.102354</ArticleId><ArticleId IdType="pii">S0896-8411(19)30585-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med, 2003;349:1526&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">14561795</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera TL, Izmirly PM, Birnbaum BK, Byrne P, Brauth JB, Katholi M et al. Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus. Ann Rheum Dis, 2009;68:828&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3558032</ArticleId><ArticleId IdType="pubmed">18625627</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango MT, Perricone C, Kivity S, Cipriano E, Ceccarelli F, Valesini G et al. HLA-DRB1 the notorious gene in the mosaic of autoimmunity. Immunol Res, 2017;65:82&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">27435705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J et al. Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus. J Immunol, 2004;172:1287&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pubmed">14707107</ArticleId></ArticleIdList></Reference><Reference><Citation>Poole BD, Templeton AK, Guthridge JM, Brown EJ, Harley JB, James JA. Aberrant Epstein-Barr viral infection in systemic lupus erythematosus. Autoimmun Rev, 2009;8:337&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2822456</ArticleId><ArticleId IdType="pubmed">19167523</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosser EC, Mauri C. A clinical update on the significance of the gut microbiota in systemic autoimmunity. J Autoimmun, 2016;74:85&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">27481556</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymula A, Rosenthal J, Szczerba BM, Bagavant H, Fu SM, Deshmukh US. T cell epitope mimicry between Sjogren&#x2019;s syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. Clin Immunol, 2014;152:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4004658</ArticleId><ArticleId IdType="pubmed">24576620</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiling TM, Dehner C, Chen X, Hughes K, Iniguez AJ, Boccitto M et al. Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus. Sci Transl Med, 2018;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5918293</ArticleId><ArticleId IdType="pubmed">29593104</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol, 1998;31:1658&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pubmed">9626848</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed JH, Clancy RM, Lee KH, Saxena A, Izmirly PM, Buyon JP. Umbilical cord blood levels of maternal antibodies reactive with p200 and full-length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus. Arthritis Care Res (Hoboken), 2012;64:1373&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413772</ArticleId><ArticleId IdType="pubmed">22511615</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982;25:1271&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Petri M, Orbai AM, Alarcon GS, Gordon C, Merrill JT, Fortin PR et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum, 2012;64:2677&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3409311</ArticleId><ArticleId IdType="pubmed">22553077</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al. Classification criteria for Sjogren&#x2019;s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis, 2002;61:554&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1754137</ArticleId><ArticleId IdType="pubmed">12006334</ArticleId></ArticleIdList></Reference><Reference><Citation>Izmirly PM, Buyon JP, Wan I, Belmont HM, Sahl S, Salmon JE et al. The Incidence and Prevalence of Adult Primary Sjogren&#x2019;s Syndrome in New York County. Arthritis Care Res (Hoboken), 2019;71:949&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6347539</ArticleId><ArticleId IdType="pubmed">30044541</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel G, Crowson CS, Matteson EL, Cornec D. Prevalence of Primary Sjogren&#x2019;s Syndrome in a US Population-Based Cohort. Arthritis Care Res (Hoboken), 2017;69:1612&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5478481</ArticleId><ArticleId IdType="pubmed">27998024</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM et al. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjogren&#x2019;s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis, 2017;76:9&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pubmed">27789466</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol, 2019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6827566</ArticleId><ArticleId IdType="pubmed">31385462</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschi SK, Johnson SR, Boumpas DT, Daikh D, Dorner T, Diamond B et al. Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus. Ann Rheum Dis, 2019;78:634&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7057251</ArticleId><ArticleId IdType="pubmed">30692164</ArticleId></ArticleIdList></Reference><Reference><Citation>Costea PI, Zeller G, Sunagawa S, Pelletier E, Alberti A, Levenez F et al. Towards standards for human fecal sample processing in metagenomic studies. Nat Biotechnol, 2017;35:1069&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pubmed">28967887</ArticleId></ArticleIdList></Reference><Reference><Citation>Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods, 2016;13:581&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4927377</ArticleId><ArticleId IdType="pubmed">27214047</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz ZD, Muller CL, Miraldi ER, Littman DR, Blaser MJ, Bonneau RA. Sparse and compositionally robust inference of microbial ecological networks. PLoS Comput Biol, 2015;11:e1004226.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4423992</ArticleId><ArticleId IdType="pubmed">25950956</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamont RJ, Koo H, Hajishengallis G. The oral microbiota: dynamic communities and host interactions. Nat Rev Microbiol, 2018;16:745&#x2013;59.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6278837</ArticleId><ArticleId IdType="pubmed">30301974</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Ainsworth HC, Cunninghame Graham DS, Kelly JA, Comeau ME, Marion MC et al. Transancestral mapping and genetic load in systemic lupus erythematosus. Nat Commun, 2017;8:16021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5520018</ArticleId><ArticleId IdType="pubmed">28714469</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanscombe KB, Morris DL, Noble JA, Dilthey AT, Tombleson P, Kaufman KM et al. Genetic fine mapping of systemic lupus erythematosus MHC associations in Europeans and African Americans. Hum Mol Genet, 2018;27:3813&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6196648</ArticleId><ArticleId IdType="pubmed">30085094</ArticleId></ArticleIdList></Reference><Reference><Citation>Lessard CJ, Li H, Adrianto I, Ice JA, Rasmussen A, Grundahl KM et al. Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren&#x2019;s syndrome. Nat Genet, 2013;45:1284&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3867192</ArticleId><ArticleId IdType="pubmed">24097067</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa JD, Calderaro DC, Ferreira GA, Mendonca SM, Fernandes GR, Xiao E et al. Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome, 2017;5:34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5359961</ArticleId><ArticleId IdType="pubmed">28320468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, Ling G, Ding N, Xun Z, Zhu C, Hua H et al. Molecular analysis of oral microflora in patients with primary Sjogren&#x2019;s syndrome by using high-throughput sequencing. PeerJ, 2018;6:e5649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6166617</ArticleId><ArticleId IdType="pubmed">30280027</ArticleId></ArticleIdList></Reference><Reference><Citation>Belda-Ferre P, Alcaraz LD, Cabrera-Rubio R, Romero H, Simon-Soro A, Pignatelli M et al. The oral metagenome in health and disease. ISME J, 2012;6:46&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3246241</ArticleId><ArticleId IdType="pubmed">21716308</ArticleId></ArticleIdList></Reference><Reference><Citation>Aas JA, Griffen AL, Dardis SR, Lee AM, Olsen I, Dewhirst FE et al. Bacteria of dental caries in primary and permanent teeth in children and young adults. J Clin Microbiol, 2008;46:1407&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2292933</ArticleId><ArticleId IdType="pubmed">18216213</ArticleId></ArticleIdList></Reference><Reference><Citation>Casarin RC, Barbagallo A, Meulman T, Santos VR, Sallum EA, Nociti FH et al. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J Periodontal Res, 2013;48:30&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22762355</ArticleId></ArticleIdList></Reference><Reference><Citation>de Groot PF, Belzer C, Aydin O, Levin E, Levels JH, Aalvink S et al. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. PLoS One, 2017;12:e0188475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5718513</ArticleId><ArticleId IdType="pubmed">29211757</ArticleId></ArticleIdList></Reference><Reference><Citation>Long J, Cai Q, Steinwandel M, Hargreaves MK, Bordenstein SR, Blot WJ et al. Association of oral microbiome with type 2 diabetes risk. J Periodontal Res, 2017;52:636&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5403709</ArticleId><ArticleId IdType="pubmed">28177125</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielkind P, Jentsch H, Eschrich K, Rodloff AC, Stingu CS. Prevalence of Actinomyces spp. in patients with chronic periodontitis. Int J Med Microbiol, 2015;305:682&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">26324012</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis a6nd partly normalized after treatment. Nature medicine, 2015;21:895&#x2013;905.</Citation><ArticleIdList><ArticleId IdType="pubmed">26214836</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasidze I, Li J, Quinque D, Tang K, Stoneking M. Global diversity in the human salivary microbiome. Genome Res, 2009;19:636&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2665782</ArticleId><ArticleId IdType="pubmed">19251737</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Tang CM, Exley RM. Non-pathogenic Neisseria: members of an abundant, multi-habitat, diverse genus. Microbiology, 2015;161:1297&#x2013;312.</Citation><ArticleIdList><ArticleId IdType="pubmed">25814039</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A et al. Shared gut, but distinct oral microbiota composition in primary Sjogren&#x2019;s syndrome and systemic lupus erythematosus. J Autoimmun, 2019;97:77&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">30416033</ArticleId></ArticleIdList></Reference><Reference><Citation>Paisansinsup T, Deshmukh US, Chowdhary VR, Luthra HS, Fu SM, David CS. HLA class II influences the immune response and antibody diversification to Ro60/Sjogren&#x2019;s syndrome-A: heightened antibody responses and epitope spreading in mice expressing HLA-DR molecules. J Immunol, 2002;168:5876&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">12023392</ArticleId></ArticleIdList></Reference><Reference><Citation>Konto-Ghiorghi Y, Mairey E, Mallet A, Dumenil G, Caliot E, Trieu-Cuot P et al. Dual role for pilus in adherence to epithelial cells and biofilm formation in Streptococcus agalactiae. PLoS Pathog, 2009;5:e1000422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2674936</ArticleId><ArticleId IdType="pubmed">19424490</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>